Does pharmacotherapy for attention-deficit/hyperactivity disorder predict risk of later major depression?

Journal of Child and Adolescent Psychopharmacology

Volumn 18, Issue 3, 2008, Pages 257-264

  Daviss, W Burleson ^a   Birmaher, Boris ^b   Diler, Rasim S ^b   Mintz, James ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CASE CONTROL STUDY; CHILD; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDUCATIONAL STATUS; FEMALE; HUMAN; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MENTAL HEALTH CENTER; OBSERVATIONAL STUDY; OCCUPATION; PREDICTION; PSYCHOTRAUMA; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCHOOL CHILD; SEX DIFFERENCE; SUICIDAL IDEATION; COMPARATIVE STUDY; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 58149186754     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.0100     Document Type: Article

References (32)

1. Angold A, Costello EJ, Erkanli A: Comorbidity. J Child Psychol Psychiatry 40:57-87, 1999.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
3. Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ: Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: Results from a population-based study. J Dev Behav Pediatr 27:1-10, 2006.
4. Barkley RA, Biederman J: Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36:1204-1210, 1997.
5. Biederman J, Mick E, Faraone SV: Depression in attention deficit hyperactivity disorder (ADHD) children: "True" depression or demoralization? J Affect Disord 47:113-122, 1998.
6. Bird HR, Shaffer D, Fisher P, Gould MS, Staghezza B, Chen JY, Hoven C: The Columbia Impairment Scale (CIS): Pilot findings on a measure of global impairment for children and adolescents. Int J Methods Psychiatr Res 3:167-176, 1993.
7. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE, Perel JM, Nelson B: Childhood and adolescent depression: A review of the past 10 years, Part I. J Am Acad Child Adolesc Psychiatry 35:1427-1439, 1996.
8. Bolanos CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ: Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood.[see comment]. Biol Psychiatry 54:1317-1329, 2003.
9. Bull K, Spiegelhalter DJ: Survival analysis in observational studies. Stat Med 16:1041-1074, 1997.
10. Bussing R, Zima BT, Gary FA, Garvan CW: Barriers to detection, help-seeking, and service use for children with ADHD symptoms. J Behav Health Serv Res 30:176-189, 2003.
11. Carlezon WA, Jr., Mague SD, Andersen SL: Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54:1330-1337, 2003.
12. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R: Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301:386-389, 2003.
13. Chapman DP, Whitfield CL, Felitti VJ, Dube SR, Edwards VJ, Anda RF: Adverse childhood experiences and the risk of depressive disorders in adulthood. J Affect Disord 82:217-225, 2004.
14. Costello EJ, Benjamin R, Angold A, Silver D: Mood variability in adolescents: A study of depressed, nondepressed and comorbid patients. J Affect Disord 23:199-212, 1991.
15. Daviss WB, Birmaher B, Melhem NA, Axelson DA, Michaels SM, Brent DA: Criterion validity of the Mood and Feelings Questionnaire for depressive episodes in clinic and non-clinic subjects. J Child Psychol Psychiatry 47:927-934, 2006.
16. DelBello MP, Soutullo CA, Hendricks W, Niemeier RT, McElroy SL, Strakowski SM: Prior stimulant treatment in adolescents with bipolar disorder: Association with age at onset. Bipolar Disord 3:53-57, 2001.
17. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R: ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York City, NY: Guilford Publications 1998.
18. Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, Nilsson M, Jacobson JG: Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41:1205-1215, 2002.
19. Flament MF, Cohen D, Choquet M, Jeammet P, Ledoux S: Phenomenology, psychosocial correlates, and treatment seeking in major depression and dysthymia of adolescence. J Am Acad Child Adolesc Psychiatry 40:1070-1078, 2001.
20. Ford JD, Racusin R, Daviss WB, Ellis CG, Thomas J, Rogers K, Reiser J, Schiffman J, Sengupta A: Trauma exposure among children with oppositional defiant disorder and attention deficit-hyperactivity disorder. J Consult Clin Psychol 67:786-789, 1999.
21. Hollingshead AB: Four Factor Index of Social Status. New Haven, CT: Yale University Press 1975.
22. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
23. Kendler KS, Kuhn JW, Prescott CA: Childhood sexual abuse, stressful life events and risk for major depression in women. Psychol Med 34:1475-1482, 2004.
24. Kovacs M, Obrosky DS, Gatsonis C, Richards C: First-episode major depressive and dysthymic disorder in childhood: Clinical and sociodemographic factors in recovery. J Am Acad Child Adolesc Psychiatry 36:777-784, 1997.
25. Pliszka S, AACAP-Work-Group-on-Quality-Issues: Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46:894-921, 2007.
26. Pliszka SR: Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: An overview. J Clin Psychiatry 59 Suppl 7:50-58, 1998.
27. Poznanski E, Freman L, Mokros H: Children's Depression Rating Scale-Revised. Psychopharmacol Bull 21:979-989, 1985.
28. Spencer T, Biederman J, Wilens T: Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am 46:915-927, 1999.
29. Waxmonsky J: Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness. Curr Opin Pediatr 15:476-482, 2003.
30. Weissman MM, Sholomskas D, John K: The assessment of social adjustment. An update. Arch Gen Psychiatry 38:1250-1258, 1981.
31. Widom CS, DuMont K, Czaja SJ: A prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up. Arch Gen Psychiatry 64:49-56, 2007.
32. Wilens TE, Spencer TJ: The stimulants revisited. Child Adolesc Psychiatr Clin N Am 9:573-603, 2000.